356783-31-8: 6-Fluoro-3-hydroxypyrazine-2-carbonitrile
6-Fluoro-3-hydroxypyrazine-2-carbonitrile (CAS No. 356783-31-8) or 6-fluoro-3-hydroxypyrazine-2-carbonitrile is used in the synthesis of intermediate of Favipiravir. Favipiravir belongs to a group of antiviral medicines employed to treat coronavirus disease. and also indicated for the treatment of influenza, ebola, and other pathogenic viral infections.
Additional information on CAS 356783-31-8
Catalogue No.
VE007870
CAS No.
356783-31-8
Molecular Formula
C5H2FN3O
Molecular Weight
139.09 g/mol
Parent drug
Favipiravir
IUPAC Name
6-fluoro-3-hydroxypyrazine-2-carbonitrile
Synonyms
N/A
References
“Sci-Hub, Role of Favipiravir in the Treatment of COVID-19, 10.1016/J.ijid.2020.10.069.” Hkvisa.net, 2020, sci-hub.hkvisa.net/10.1016/j.ijid.2020.10.069.
Status
In-stock
